Borviz 3.5mg Injection

About

Borviz 3.5mg Injection is a highly specialized antineoplastic agent, commonly identified as a proteasome inhibitor, utilized in the treatment of various hematological malignancies, most notably multiple myeloma and mantle cell lymphoma. Its mechanism of action involves reversibly inhibiting the 26S proteasome, a multi-enzyme complex responsible for degrading ubiquitinated proteins. This inhibition disrupts cellular homeostasis, leading to an accumulation of misfolded proteins, activation of pro-apoptotic pathways, and ultimately, the death of cancer cells. Borviz is a critical component of combination therapy regimens, enhancing the efficacy of other anticancer agents and improving patient response rates. Administered under strict medical supervision, it offers a targeted approach to combat aggressive cancers, aiming to achieve remission, prolong survival, and improve the overall quality of life for patients undergoing treatment.

Uses

• Treatment of multiple myeloma
• Management of mantle cell lymphoma
• Therapy for other hematological malignancies
• Used in specific solid tumor protocols

Directions For Use

Administered intravenously or subcutaneously by a qualified healthcare professional.

Benefits

• Inhibits cancer cell growth effectively
• Induces apoptosis in malignant cells
• Overcomes drug resistance mechanisms
• Prolongs remission periods
• Provides targeted anti-cancer action
• Improves overall treatment response

Side Effects

• Nausea and vomiting
• Diarrhea or constipation
• Fatigue and weakness
• Peripheral neuropathy (nerve damage)
• Thrombocytopenia (low platelet count)
• Neutropenia (low white blood cell count)
• Fever
• Skin rash
• Headache
• Muscle weakness
• Anemia
• Hypotension (low blood pressure)

Safety Measures

• Alcohol - Avoid or limit alcohol consumption, as it may exacerbate side effects or liver issues.
• Pregnancy - Contraindicated; causes fetal harm. Use effective contraception during treatment and for a period after.
• Breastfeeding - Contraindicated; potential harm to the infant. Do not breastfeed during treatment.
• Liver - Use with extreme caution; monitor liver function closely and regularly.
• Kidney - Use with caution; dose adjustment may be necessary based on kidney function.
• Lung - Monitor for symptoms of pulmonary hypertension or acute respiratory distress syndrome.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.